Prostate Cancer | Specialty

The OncLive Prostate Cancer condition center page is a comprehensive resource for clinical news and expert insights on how to approach treatment for patients with nonmetastatic, castration-resistant, or castration-sensitive prostate cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, ongoing research, and treatment advances with androgen receptor inhibitors, PARP inhibitors, and more in prostate cancer.

Immunotherapies: Avoiding Collisions Once the Brake Is Released

June 11th 2011

Immunotherapies made headlines in oncology last month when the Centers for Medicare & Medicaid Services (CMS) decided that the anticancer vaccine sipuleucel-T (Provenge) will be a payable expense for prostate cancer.

PSA: To Screen or Not to Screen?

June 10th 2011

Screening for prostate cancer does work, despite controversy about its efficacy

Bone-Targeted Therapeutics

June 10th 2011

Therapies that target bone metastases have been developed for more than a decade.

Integrating New Hormonal Therapies in Advanced Disease

June 10th 2011

Hormonal therapies have long been the standard of care for metastatic advanced prostate cancer

The Overtreatment of Prostate Cancer

June 10th 2011

Increased prostate cancer screening has led to overtreatment and has not significantly reduced mortality rates in prostate cancer.

Novel vaccine approaches: Prospects for PROSTVAC-VF Are Bright

June 8th 2011

PROSTVAC-VF uses the smallpox viral vector to stimulate the immune system.

Circulating Tumor Cells Show Promise as Surrogate for Survival in Prostate Cancer Trials

June 5th 2011

Prostate cancer research lacks surrogate biomarkers for survival that could hasten the study and approval of new medications.

ADT for Prostate Cancer May Lead to Rapid, Significant Weight Gain

June 1st 2011

New data show that most prostate cancer patients who receive androgen-deprivation therapy gain a significant amount of weight within a year of starting treatment

High-Risk Care Varies Widely

May 31st 2011

Many clinicians are not employing radiation therapy used in combination with androgen deprivation therapy even though guidelines suggest they should

Link Between Surgical Robot Purchase and Increase in Prostate Cancer Surgery Rate

May 27th 2011

New data suggested that hospitals that purchase a surgical robot experience a subsequent hike in the number of radical prostatectomies

Abiraterone Acetate Improves Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer

May 26th 2011

Men with advanced CRPC who were treated with abiraterone acetate plus prednisone/prednisolone had significant improvement in overall survival

Donna Berry Discusses Her Prostate Cancer Research

May 24th 2011

Donna Berry Discusses Her Prostate Cancer Research

NCCN's 16th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care

May 24th 2011

Each year the National Comprehensive Cancer Network (NCCN) presents the latest updates to its Clinical Practice Guidelines in Oncology, as well as the latest cancer therapies by key opinion leaders.

Juanita Madison on Handling the Provenge Process

May 23rd 2011

Juanita Madison from the Seattle Cancer Care Alliance on Handling the Provenge Treatment Process

Juanita Madison Describes the Provenge Treatment Process

May 20th 2011

Juanita Madison from Seattle Cancer Care Alliance Describes the Provenge Treatment Process

Suzanne Beauchene on the Provenge Treatment Process

May 20th 2011

Suzanne Beauchene from Seattle Cancer Care Alliance Discusses the Provenge Treatment Process from Start to Finish

PSA Found to Be Highly Predictive of Long-Term Risk of Death From Prostate Cancer

May 18th 2011

Prostate-specific antigen (PSA) levels can accurately predict the risk of developing metastasis or death from prostate cancer up to 30 years later

Dr. Markman Discusses the Swedish PSA Screening

May 18th 2011

Dr. Markman Discusses the Swedish PSA Screening

Dr. Pecora on Results from the Swedish PSA Study

May 18th 2011

Dr. Pecora on Results from the Swedish PSA Study

Dr. Markman Discusses the Importance of Screening

May 18th 2011

Dr. Markman Discusses the Importance of Cancer Screening